Back to Search
Start Over
Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway
- Source :
- Clinical Lymphoma Myeloma and Leukemia. 21:S221
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 21522650
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Clinical Lymphoma Myeloma and Leukemia
- Accession number :
- edsair.doi...........e55e2a90587fdea492ad68b03a7fdfff